Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing rituximab with combination chemotherapy for non-Hodgkin's lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: German High-Grade Non-Hodgkin's Lymphoma Study Group | Conditions: Lymphoma | Phase 3 | Status: COMPLETED